GEN Exclusives

More »

GEN News Highlights

More »
Mar 31, 2009

Mount Sinai Taps DiscoveryBioMed for Drug Discovery Programs

  • Mount Sinai School of Medicine (MSSM) is employing DiscoveryBioMed (DBM) in fee-for-service contracts covering basic drug discovery work. The agreement calls for human cell optimization, assay optimization, and drug discovery bioassays.

    Experiments have reportedly commenced on assay optimization, and pilot drug screening will begin shortly. The firm is using its expertise in the development and engineering of human cell cultures and lines from normal or diseased tissue.



Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

New Drugs for Ebola

Do you think that biopharma companies should not have to go through the normal drug approval process in order to get potential life-saving therapies to Ebola patients more quickly?